Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health topic

No spam. Unsubscribe anytime.

House approves Delaware Diabetes Wellness pilot to test technology-enabled care for Type 2 diabetes

House of Representatives · June 16, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

House Bill 3 05 establishes a multi-year pilot using continuous glucose monitoring, expanded lab testing, care coordinators and data analysis to improve outcomes for people with Type 2 diabetes, with a 3-year sunset and state reporting requirements.

The House passed House Bill 3 05 on June 16, authorizing a Delaware Diabetes Wellness Pilot that will invite a target cohort of patients to participate in a technology-enabled, data-driven program.

Sponsor Representative Pawlowski described the pilot as an evidence-based effort to shift diabetes care from reactive sick care to proactive well care using continuous glucose monitors, comprehensive lab panels, dietitian counseling, care coordination and analysis through the Delaware Health Information Network (DIN). "House bill 3 05 will utilize the best technology system to empower patients to better understand and help them control their own health destiny," Pawlowski said.

The House adopted an amendment directing the secretary to make reasonable efforts to ensure the enrolled population reflects racial, ethnic, socioeconomic, geographic, age and gender diversity consistent with epidemiological data. Sponsors said the pilot will enroll up to 400 invited participants, will include a de-identified control group, and is designed to be evaluated over a defined period with mandatory reporting to the General Assembly.

Why it matters: Type 2 diabetes is a leading driver of health care costs and chronic complications. The pilot aims to test whether integrated monitoring, coaching and advanced lab analytics can improve outcomes and reduce utilization. Supporters said the program is data-driven, includes safeguards for privacy and aims to reduce medication costs through improved management.

The bill passed the House by roll-call and includes a sunset provision after the pilot period, with reporting requirements to the General Assembly.